Results 261 to 270 of about 38,544 (277)

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1

ACS Medicinal Chemistry Letters, 2014
Steven R Laplante, Craig Fenwick, Stephen Mason   +2 more
exaly  

HIV integrase inhibitor-based regimen beats market leader

Nature Reviews Drug Discovery, 2012
exaly  

Hiv integrase inhibitors

2008
Summa V, Kinzel, Olaf, Donghi, Monica
openaire   +1 more source

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor

HIV Clinical Trials, 2013
exaly  

Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients

HIV Clinical Trials, 2014
exaly  

Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection

Annals of Pharmacotherapy, 2014
exaly  

Elvitegravir: a once-daily inhibitor of HIV-1 integrase

Expert Opinion on Investigational Drugs, 2012
exaly  

Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor

Expert Review of Anti-Infective Therapy, 2012
exaly  

Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection

Expert Opinion on Investigational Drugs, 2008
exaly